…2024, 232 WGwH indicated that they had severe (n=70), moderate (n=26) or mild (n=136) factor deficiency and 407 NoBD were available for comparison. Prophylaxis use was 65.71% in WGwH classified…
Results for "prophylaxis"
Impact of Switching to Prophylaxis with Recombinant Factor IX Fc Fusion Protein Concentrate on Patient Reported Outcomes in People with Haemophilia B Using the PROBE Questionnaire
O’Donovan M, Johnston K, Singleton E, Benson J, Ryan K, O’Connell N. Impact of Switching to Prophylaxis with Recombinant Factor IX Fc Fusion Protein Concentrate on Patient Reported Outcomes in…
Mapping outcomes to coreVWD: moving toward a fully reportable core outcome set to improve access to treatment for people with von Willebrand Disease (VWD)
…procedures Bleed control: with prophylaxis prior to surgery BAT Score2, Treatment Module Patient-reported bleed, Patient-reported treatment Bleed control: without prophylaxis prior to surgery BAT Score2, Treatment Module Number of administrations…
Abstracts
…the PROBE Study [abstract]. Res Pract Thromb Haemost. 2020;4(Suppl 1). https://abstracts.isth.org/abstract/association-between-aging-and-health-status-in-persons-leaving-with-hemophilia-and-controls-without-a-bleeding-disorder-insights-from-the-probe-study/. Accessed June 29, 2020. Impact of Switching to Prophylaxis with Recombinant Factor IX Fc Fusion Protein Concentrate on Patient…
PROBE Results Show Continued Burden of Disease in Canadians with Hemophilia A and B
…Prophylaxis with recombinant factor concentrates has been the standard of care for severe hemophilia A and B in Canada since the early 1990s and has resulted in significantly improved quality-of-life;…
Patient-Reported Outcomes in Hemophilia in Kosovo: Results from the PROBE Questionnaire
…on regular prophylaxis, with half relying on intermittent regimens and some reporting no treatment availability. Findings highlight persistent unmet needs in access to regular prophylaxis, pain management, and joint health….
Comparing Health Outcomes for Women and Girls with Hemophilia and No Bleeding Disorder – Insights from the Patient Reported Outcomes Burdens and Experiences (PROBE) Study
…2015 to 2024, 232 WGwH indicated that they had severe (n=70), moderate (n=26) or mild (n=136) factor deficiency and 407 NoBD were available for comparison. Prophylaxis use was 65.71% in…
Publications 2020
…# PB 0981 Impact of Switching to Prophylaxis with Recombinant Factor IX Fc Fusion Protein Concentrate on Patient Reported Outcomes in People with Haemophilia B Using the PROBE Questionnaire…
Assessment of quality of life of patients in Kyrgyzstan using the PROBE tool
…(n=1) and 27.0% (n=10) were severe, moderate, mild or of those whom reported they do not know their severity level. 18.9% (n=7) reported access to some prophylaxis; 59.5% (n=22) and…
Exploring the Quality Of Life And Self‐Reported Outcomes Of Patients With Hemophilia A In A Cross‐Sectional Study In Colombia
…administered at home in 72% of patients, with regular prophylaxis as the most common treatment regimen. In terms of overall HRQoL, measured by EQ‐5D VAS, the mean score reported by…


